Showing results (31-40 of 1,205) with videos related to
Sort By:
Pageof 121
Trends in Molecular Medicine|December 9, 2003
Molecular aspects of bile formation and cholestasisMarco Arrese, Michael TraunerBritish Journal of Pharmacology|January 13, 2009
Nuclear receptors as therapeutic targets in cholestatic liver diseasesGernot Zollner, Michael TraunerJournal of Hepatology|January 23, 2009
When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosisPeter Fickert, Michael TraunerWiener Medizinische Wochenschrift (1946)|August 29, 2006
Molecular mechanisms of cholestasisGernot Zollner, Michael TraunerJournal of Internal Medicine|July 7, 2022
Current treatment of non-alcoholic fatty liver diseaseRafael Paternostro, Michael TraunerThe American Journal of Pathology|January 27, 2006
Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in micePeter Fickert, Andrea Fuchsbichler, Hanns-Ulrich Marschall, et al.Journal of Lipid Research|December 6, 2005
Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acidsHanns-Ulrich Marschall, Martin Wagner, Karl Bodin, et al.Hepatology (Baltimore, Md.)|August 3, 2007
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acidTatjana Stojakovic, Csilla Putz-Bankuti, Günter Fauler, et al.Hepatology (Baltimore, Md.)|February 22, 2005
Cytokine-independent repression of rodent Ntcp in obstructive cholestasisAndreas Geier, Gernot Zollner, Christoph G Dietrich, et al.Expert Opinion on Drug Metabolism & Toxicology|March 29, 2012
Xenobiotic-induced liver injury and fibrosisChristoph H Österreicher, Michael TraunerPageof 121